New to The Street Announces the Broadcast of Show Number 675 This Saturday at 6:30 PM EST on Bloomberg Television Featuring: FLOKI, BioVie (NASDAQ: BIVI), Arrive AI ($ARAI), Health In Tech (NASDAQ HIT), and Commercialville T.V.
new to the street
Show Number 675 is sponsored programming by Ainos (NASDAQ: AIMD), Arrive AI ($ARAI), Acurx Pharmaceuticals (NASDAQ: ACXP), Sustainable Green Team (OTC: SGTM) and Commercialville T.V. commercials
New to The Street proudly announces the broadcast of Show Number 675, airing this Saturday at 6:30 PM EST on Bloomberg Television. Show Number 675 marks a major milestone for the nationally syndicated program known for its in-depth interviews and business features spanning emerging technologies, biotech, fintech, and media.
Show Number 675 will feature the following companies:
FLOKI – A leading Web3 utility and metaverse token with a growing ecosystem across blockchain, education, and decentralized finance.
BioVie Inc. (NASDAQ:BIVI) – A clinical-stage biotech company advancing therapeutic solutions for Alzheimer's and advanced liver disease.
Arrive AI ($ARAI) – A next-generation logistics platform utilizing AI to streamline smart deliveries and mail infrastructure.
Health In Tech – A digital health platform transforming underwriting and broker tools for next-gen insurance services.
Commercialville T.V. –CommercialVille T.V. is an innovative, zip‑code‑targeted, video‑based search engine designed specifically for local advertising. Using its patented technology, it delivers location‑relevant video ads directly to users based on entered zip codes and keywords.
Show Number 675 is sponsored programming brought to audiences by:
Ainos, Inc. (NASDAQ:AIMD) – Focused on developing innovative point-of-care diagnostics and therapeutic monitoring technologies.
Arrive AI ($ARAI) – Disrupting traditional logistics with AI-powered predictive infrastructure.
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) – Developing a new class of antibiotics addressing multidrug-resistant Gram-positive infections.
Commercialville T.V. – Blending entertainment and e-commerce into a measurable media platform.
Vince Caruso, CEO and C0 Founder of New to The Street, commented:
'We're excited to bring audiences Show Number 675, showcasing disruptive companies across multiple sectors. As we expand our platform on Bloomberg, Fox Business, and digital syndication, we remain committed to helping innovators scale their story and visibility.'
Show Number 675 will also stream on the New to The Street YouTube channel (2.9M+ subscribers), and be shared across social media and digital distribution networks globally.
For media, sponsorship, or interview inquiries related to Show Number 675:
Monica Brennan
Monica@NewToTheStreet.com
About New to The Street
Since 2009, New to The Street has produced over 675 episodes, airing weekly on Bloomberg Television and Fox Business as sponsored programming. Known for combining linear TV with digital media, social amplification, and billboard coverage, New to The Street provides a powerful media platform for public and private companies looking to elevate their visibility.
SOURCE: New To The Street
View the original press release on ACCESS Newswire
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
12 minutes ago
- Yahoo
Most Asian stocks rise as investors eye US trade talks
Asian equities mostly rose Monday following a record-breaking day on Wall Street as investors kept tabs on countries' efforts to strike trade deals with the United States before a key deadline next week. And the dollar weakened on growing expectations for more interest rate cuts, while eyes were on Donald Trump's signature tax-cutting bill -- now inching towards a Senate vote -- that some experts warn could add trillions of dollars to the national debt. The S&P 500 and Nasdaq finished at all-time peaks Friday amid optimism governments will be able to avoid swingeing tariffs imposed by the US president in April and paused until July 9 to allow for negotiations. Officials from Japan and India have extended their stays in Washington to continue talks, raising hopes for agreements with two of the world's biggest economies. Hopes that the deadline could be extended were boosted Friday by Treasury Secretary Scott Bessent, who told Fox Business "we have countries approaching us with very good deals" but they might not all be finalised by next week. But he added: "If we can ink 10 or 12 of the important 18 -- there are another important 20 relationships -- then I think we could have trade wrapped up by Labor Day," which falls on September 1. Trump said at the weekend that he did not expect to extend the deadline, telling the "Sunday Morning Futures with Maria Bartiromo" show: "I don't think I'll need to". "I could, no big deal," he added in the interview that was taped Friday. Meanwhile, Canadian Finance Minister Francois-Philippe Champagne said Sunday that Ottawa would rescind taxes impacting US tech firms in hopes of reaching a trade agreement with Washington after Trump called off talks in retaliation for the levy. Negotiations would resume with the aim of getting a deal by July 21, Ottawa added. After Wall Street's record day, most of Asia followed suit. Tokyo extended its recent rally fuelled by tech firms, while there were also gains in Shanghai, Sydney, Seoul, Singapore, Manila and Jakarta. But Hong Kong, Wellington and Taipei fell. There was little major reaction to data showing the contraction in Chinese factory activity eased further in June after a China-US trade truce. The dollar extended losses against its peers as traders increased bets on at least two rate cuts this year following Trump's indication he could choose a successor to Federal Reserve boss Jerome Powell within months. "Markets... are already pricing not just two Fed cuts this year, but a full-blown easing cycle stretching deep into 2026," said SPI Asset Management's Stephen Innes. "Powell may still hold the gavel, but traders are betting the next Fed chair walks, talks, and cuts like a dove in MAGA red." Senators were also debating Trump's "One Big Beautiful Bill", which extends his expiring first-term tax cuts at a cost of $4.5 trillion and beefs up border security. The Republican president has ramped up pressure to get the package to his desk by July 4, and called out wavering lawmakers from his party. However, there are worries about the impact on the economy, with the nonpartisan Congressional Budget Office estimating the measure would add nearly $3.3 trillion to US deficits over a decade. - Key figures at around 0230 GMT - Tokyo - Nikkei 225: UP 1.6 percent at 40,809.82 (break) Hong Kong - Hang Seng Index: DOWN 0.4 percent at 24,183.73 Shanghai - Composite: UP 0.3 percent at 3,433.80 Euro/dollar: UP at $1.1724 from $1.1718 on Friday Pound/dollar: UP at $1.3723 from $1.3715 Dollar/yen: DOWN at 144.31 yen from 144.68 yen Euro/pound: UP at 85.45 pence from 85.43 pence West Texas Intermediate: DOWN 0.5 percent at $65.18 per barrel Brent North Sea Crude: DOWN 0.3 percent at $67.57 per barrel New York - Dow: UP 1.0 percent at 43,819.27 (close) London - FTSE 100: UP 0.7 percent at 8,798.91 (close) dan/sco Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
3 hours ago
- Yahoo
Stock market today: Dow, S&P 500 and Nasdaq futures rise as stocks set to end June with a bang
US stock futures edged higher Sunday evening, setting up the major indexes for more records to end one of the most volatile first halves of a year in recent memory. Futures tied to the Dow Jones Industrial Average (YM=F) rose around 0.5%. Contracts on the S&P 500 (ES=F) gained 0.2%, and Nasdaq 100 (NQ=F) futures ticked up 0.3%. Several of Trump's economic agenda items are in focus this week. A July 9 deadline looms before the possible resumption of Trump's unilateral tariffs, which Trump on Sunday said he didn't think he'd "need to" extend. On the trade front, India has extended its Washington visit to finalize a deal. Administration officials last week confirmed a trade framework with China was in place, bolstering investor sentiment despite a late-Friday dip triggered by Trump's abrupt halt to talks with Canada, citing its digital tax policy. Meanwhile, market watchers are closely following Senate negotiations over Trump's proposed $4.5 trillion tax cut bill. The measure, which passed a procedural vote Saturday, could face a tough path in the House. The Congressional Budget Office estimates it would add $3.3 trillion to the deficit over a decade. For the market, June's gains have been substantial, fueled by optimism surrounding global trade and easing fears over tariffs. The S&P 500 (^GSPC) is up over 4%, the Nasdaq Composite (^IXIC) has surged over 5.5%, and the Dow (^DJI) has climbed 3.5%. On Friday, all three major indexes closed higher, with the S&P and Nasdaq reaching new record highs for the first time since February — the start of the year's tariff-fueled stock swings. All three major indexes are up at least 3% so far this year. Looking ahead, investors will monitor key Chinese PMI data due Monday to gauge how the ongoing trade war is affecting Asia's largest economy. Despite lingering uncertainties, the broader market remains upbeat heading into the new quarter and second half.
Yahoo
4 hours ago
- Yahoo
Portage Biotech Regains Full Compliance with Nasdaq Continued Listing Requirements
DOVER, Del., June 25, 2025 (GLOBE NEWSWIRE) -- Portage Biotech Inc. ('Portage' or the 'Company') (NASDAQ: PRTG), a clinical-stage immuno-oncology company formed under the laws of the British Virgin Islands ('Portage'), announced today that on June 24, 2025, the Company received formal notice from The Nasdaq Stock Market LLC that the Company has evidenced compliance with all applicable requirements for continued listing on The Nasdaq Capital Market. About Portage BiotechPortage Biotech is a clinical-stage immuno-oncology company advancing a pipeline of novel biologics to transform the immune system's ability to fight cancer. For more information, visit Forward-Looking StatementsAll statements in this news release, other than statements of historical facts, including without limitation, statements regarding the Company's business strategy, plans and objectives of management for future operations and those statements preceded by, followed by or that otherwise include the words 'believe,' 'expects,' 'anticipates,' 'intends,' 'estimates,' 'will,' 'may,' 'plans,' 'potential,' 'continues,' or similar expressions or variations on such expressions are forward-looking statements. As a result, forward-looking statements are subject to certain risks and uncertainties, including, but not limited to: the risk that the Company may not secure financing, the uncertainty of the Company's ability to continue as a going concern, scientific results may not be as expected, and other factors set forth in 'Item 3 - Key Information-Risk Factors' in the Company's Annual Report on Form 20-F for the year ended March 31, 2024 and 'Business Environment – Risk Factors' in the Company's Management's Discussion and Analysis for the Three and Six Months ended September 30, 2024, filed as Exhibit 99.2 to the Company's Form 6-K. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, undue reliance should not be placed on them as actual results may differ materially from these forward-looking statements. The forward-looking statements contained in this news release are made as of the date hereof, and the Company undertakes no obligation to update publicly or revise any forward-looking statements or information, except as required by law. For More Information:Portage BiotechAlexander Pickett, Chief Executive Officerir@ while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
